Diagnosis of Tay-Sachs disease by estimation of β-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 137 (2) , 159-168
- https://doi.org/10.1016/0009-8981(84)90176-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Impaired degradation of chondroitin sulfate in GM2-gangliosidosisClinical Genetics, 2008
- Degradation of keratan sulfate by ß-N-acetylhexosaminidases in GM2-gangliosidosisClinical Genetics, 2008
- N-[3H]acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycansAnalytical Biochemistry, 1982
- Evidence for Different Glycohydrolase and Glycosyltransferase Activities of 3- N -Acetylglucosaminidases A and BHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1975
- Sandhoff Disease: Defective Glycosaminoglycan Catabolism in Cultured Fibroblasts and Its Correction by β‐N‐AcetylhexosaminidaseEuropean Journal of Biochemistry, 1974
- N -Acetyl-β-hexosaminidase: Role in the Degradation of GlycosaminoglycansScience, 1973
- The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissueJournal of Clinical Investigation, 1972
- Tay-Sachs Disease: Generalized Absence of a Beta-D- N -Acetylhexosaminidase ComponentScience, 1969
- N-Acetyl-β-glucosaminidases in human spleenBiochemical Journal, 1968
- Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organsLife Sciences, 1968